Pages that link to "Q34170552"
Jump to navigation
Jump to search
The following pages link to NVP-BEZ-235 enhances radiosensitization via blockade of the PI3K/mTOR pathway in cisplatin-resistant non-small cell lung carcinoma (Q34170552):
Displaying 21 items.
- New perspectives in glioblastoma antiangiogenic therapy (Q26746028) (← links)
- To live or let die: Unclear task of autophagy in the radiosensitization battle (Q26753280) (← links)
- Therapeutic Implications for Overcoming Radiation Resistance in Cancer Therapy (Q26777016) (← links)
- AUTEN-67, an autophagy-enhancing drug candidate with potent antiaging and neuroprotective effects (Q28834576) (← links)
- Targeted PI3K/AKT/mTOR therapy for metastatic carcinomas of the cervix: A phase I clinical experience (Q34957243) (← links)
- Tumor cells switch to mitochondrial oxidative phosphorylation under radiation via mTOR-mediated hexokinase II inhibition--a Warburg-reversing effect (Q35217017) (← links)
- A novel PI3K inhibitor PIK-C98 displays potent preclinical activity against multiple myeloma (Q35238420) (← links)
- p22phox confers resistance to cisplatin, by blocking its entry into the nucleus. (Q35551953) (← links)
- Inhibition of DNA methyltransferase as a novel therapeutic strategy to overcome acquired resistance to dual PI3K/mTOR inhibitors (Q35741623) (← links)
- Radiation Enhancement of Head and Neck Squamous Cell Carcinoma by the Dual PI3K/mTOR Inhibitor PF-05212384. (Q35751948) (← links)
- PI3K/AKT/mTOR and sonic hedgehog pathways cooperate together to inhibit human pancreatic cancer stem cell characteristics and tumor growth (Q36544764) (← links)
- Influence of autophagy on the efficacy of radiotherapy (Q37713509) (← links)
- Autophagy is not uniformly cytoprotective: a personalized medicine approach for autophagy inhibition as a therapeutic strategy in non-small cell lung cancer (Q38868651) (← links)
- MEK inhibitors cobimetinib and trametinib, regressed a gemcitabine-resistant pancreatic-cancer patient-derived orthotopic xenograft (PDOX) (Q41471129) (← links)
- Targeting the PI3K/AKT/mTOR signaling pathway as an effectively radiosensitizing strategy for treating human oral squamous cell carcinoma in vitro and in vivo (Q42093380) (← links)
- Radiosensitization of the PI3K inhibitor HS-173 through reduction of DNA damage repair in pancreatic cancer (Q49451574) (← links)
- New Insights into Protein Kinase B/Akt Signaling: Role of Localized Akt Activation and Compartment-Specific Target Proteins for the Cellular Radiation Response. (Q52644526) (← links)
- NVP-BEZ235 synergizes cisplatin sensitivity in osteosarcoma. (Q52657087) (← links)
- Expression profiling analysis of autophagy-related genes in perineural invasion of cutaneous squamous cell carcinoma. (Q54120670) (← links)
- Novel biological strategies to enhance the radiation therapeutic ratio (Q57494906) (← links)
- Icariin enhances the chemosensitivity of cisplatin‑resistant ovarian cancer cells by suppressing autophagy via activation of the AKT/mTOR/ATG5 pathway. (Q64883426) (← links)